These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5605930)

  • 1. [A new MAO inhibitor in the therapy of depressions: MO-1255].
    Herrera JJ; Bauza MA; Nazar J
    Prensa Med Argent; 1967 May; 54(13):591-8. PubMed ID: 5605930
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study of a new antidepressant inhibitor of monoamine oxidase: R.C. 41.10].
    Lafon R; Minvielle J; Chapel A; Chabanier J
    Therapie; 1966; 21(6):1405-11. PubMed ID: 6002648
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical studies with MO-1255, a new monoamine oxidase inhibitor antidepressant.
    Ban TA; St-Jean A; Lehmann HE
    Curr Ther Res Clin Exp; 1966 Dec; 8(12):614-6. PubMed ID: 4962732
    [No Abstract]   [Full Text] [Related]  

  • 4. [Indications and results of the treatment of mental depression by octamoxine (ximaol)].
    Gayral L; Stern H; Puyuelo R
    Therapie; 1966; 21(5):1183-90. PubMed ID: 5976767
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychopharmacological dissection of nonendogenous depression.
    Liebowitz MR; Quitkin FM; Stewart JM; McGrath P; Harrison W; Rabkin JG; Klein DF
    Psychopharmacol Bull; 1984; 20(3):390-2. PubMed ID: 6473638
    [No Abstract]   [Full Text] [Related]  

  • 6. [Notes on the use of monoamine oxidase inhibitor drugs].
    Gayral L
    Therapie; 1966; 21(5):1175-81. PubMed ID: 5976766
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoamine oxidase inhibitors.
    Masters AB
    Can Med Assoc J; 1971 Dec; 105(12):1281. PubMed ID: 5150330
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of hydrazino-2-octane in a general medicine department].
    Arnaud P; Pousset G; Plauchu M
    Lyon Med; 1966 Nov; 216(45):983-98. PubMed ID: 5983666
    [No Abstract]   [Full Text] [Related]  

  • 9. [Relation between glucose tolerance and depression and its therapy using monoamine oxidase inhibitors and lithium salts].
    Pürgyi P
    Nervenarzt; 1972 Jul; 43(7):379-82. PubMed ID: 5047936
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug therapy of depressions and depression research].
    Pöldinger W
    Wien Med Wochenschr; 1967 Jan; 117(3):69-75. PubMed ID: 4870923
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversible monoamine oxidase-A inhibitors in resistant major depression.
    Nolen WA; Hoencamp E; Bouvy PF; Haffmans PM
    Clin Neuropharmacol; 1993; 16 Suppl 2():S69-76. PubMed ID: 8313400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of refractory primary depression].
    van Praag HM
    Ned Tijdschr Geneeskd; 1997 Jul; 141(28):1375-9. PubMed ID: 9380197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined and selective monoamine oxidase inhibition in the treatment of depression in Parkinson's disease.
    Jansen Steur EN; Ballering LA
    Adv Neurol; 1999; 80():505-8. PubMed ID: 10410764
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversal of stress-induced deficit in aggression by monoamine oxidase inhibitors.
    Ossowska G; Klenk-Majewska B; Danilczuk Z; Wróbel A; Zebrowska-Lupina I
    Pol J Pharmacol; 1999; 51(5):391-7. PubMed ID: 10817539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of depression with an mao inhibitor followed by 5-HTP--an unfinished research project.
    Kline N; Sacks W
    Acta Psychiatr Scand Suppl; 1980; 280():233-41. PubMed ID: 6996430
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experience with the use of niamid in the treatment od depressive states].
    Khivillvitskiĭ TIa; Nuller IuL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(9):1387-90. PubMed ID: 5700612
    [No Abstract]   [Full Text] [Related]  

  • 17. MAO inhibitors in clinical practice: principles based on recent research [proceedings].
    Nies A; Robinson DS; Bartlett D; Lamborn KR
    Psychopharmacol Bull; 1977 Jan; 13(1):54-5. PubMed ID: 319475
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of TV3326, a novel monoamine-oxidase cholinesterase inhibitor, in rat models of anxiety and depression.
    Weinstock M; Poltyrev T; Bejar C; Youdim MB
    Psychopharmacology (Berl); 2002 Mar; 160(3):318-24. PubMed ID: 11889501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antidepressive action, pharmacokinetic characteristics and biochemical properties of cimoxatone, a new reversible MAO-A inhibitor].
    Poirier MF; Olié JP; Lôo H; Deniker P; Strolin Benedetti M; Rovei V; Lesage A
    Encephale; 1983; 9(4):331-43. PubMed ID: 6368197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Appraisal of pharmacotherapy of affective disorders].
    Tanimukai H
    Seishin Shinkeigaku Zasshi; 1973 May; 75(5):312-20. PubMed ID: 4581050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.